Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 520 of 1,261
  1. US 10195259

    Compositions and methods for treatment of cancer using bacteria

    Decoy Biosystems, Inc. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted
  2. US 10189846

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  3. US 10188633

    Identification of small molecules that facilitate therapeutic exon skipping

    The Regents of the University of California · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  4. US 10188619

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  5. US 10188644

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  6. US 10188739

    Compositions and methods for administering insulin or insulin-like protein to the brain

    XENETIC BIOSCIENCES, INC. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  7. US 10189784

    N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase

    ACADEMISCH MEDISCH CENTRUM · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  8. US 10189881

    MPS peptides and use thereof

    The Regents of the University of California · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  9. US 10189952

    Degradable thiol-ene polymers

    The Regents of the University of Colorado, a body · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  10. US 10190118

    Methods and compositions for treating insects

    Alnylam Pharmaceuticals, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  11. US 10190129

    Increasing levels of nicotinic alkaloids in plants

    22ND CENTURY LIMITED, LLC · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  12. US 10190097

    Method and composition for inducing human pluripotent stem cells

    The Regents of the University of California · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  13. US 10189901

    Methods for improving cardiac function by administering an antibody that activates APLNR

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  14. US 10189859

    Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

    Nektar Therapeutics · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  15. US 10189872

    Crystalline form of nicotinamide riboside

    W.R. Grace & Co.-Conn. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  16. US 10189878

    Ebolavirus pre-hairpin intermediate mimics and methods of use

    The United States of America—Air Force · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  17. US 10189825

    Heteroaryl compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  18. US 10189823

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  19. US 10189809

    SGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  20. US 10189807

    Tetrahydrothiophene-based GABA aminotransferase inactivators

    Northwestern University · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  21. US 10189785

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  22. US 10188769

    Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same

    The Regents of the University of California · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  23. US 10188751

    Papillomavirus pseudoviruses for detection and therapy of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  24. US 10188755

    Magnetic microstructures for magnetic resonance imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.